New Key Statistics Module, Z-Score and F-Score
NAS:AMRX Key Ratios
Market Cap $ M | 2,469.46 |
Enterprise Value $ M | 5,099.87 |
P/E(ttm) | -- |
PE Ratio without NRI | 13.28 |
Forward PE Ratio | 10.92 |
Price/Book | -- |
Price/Sales | 0.87 |
Price/Free Cash Flow | 9.65 |
Price/Owner Earnings | 234.41 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,680.00 |
EPS (TTM) $ | -0.68 |
Beneish M-Score | -2.99 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 19.30 |
y-y EBITDA Growth Rate % | -60.90 |
EV-to-EBIT | 38.25 |
EV-to-EBITDA | 14.15 |
PEG | 0.69 |
Shares Outstanding M | 309.84 |
Net Margin (%) | -6.88 |
Operating Margin % | 10.40 |
Pre-tax Margin (%) | -4.60 |
Quick Ratio | 0.84 |
Current Ratio | 1.38 |
ROA % (ttm) | -5.24 |
ROE % (ttm) | -678.04 |
ROIC % (ttm) | 11.40 |
Dividend Yield % | -- |
Altman Z-Score | 1.24 |
AMRX Number of Guru Trades
AMRX Volume of Guru Trades
Gurus Latest Trades with NAS:AMRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AMRX is held by these investors
Total 2
Amneal Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AMRX
Total 0- 1